Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two Phase 3 studies.

Lebwohl, Mark; Iversen, Lars; Eidsmo, Liv; Krueger, James G; Suárez-Fariñas, Mayte; Tomalin, Lewis; Kolbinger, Frank; You, Ruquan; Milutinovic, Marina

Lebwohl, Mark; Iversen, Lars; Eidsmo, Liv; Krueger, James G; Suárez-Fariñas, Mayte; Tomalin, Lewis; Kolbinger, Frank; You, Ruquan; Milutinovic, Marina.

Afiliação

Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, USA.
Iversen L; Aarhus University Hospital, Aarhus, Denmark.
Eidsmo L; Department of Medicine Solna, Karolinska Institutet, Stockholm Sweden and Leo Foundation Skin Immunology Research Center.
Krueger JG; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Suárez-Fariñas M; Laboratory of Investigative Dermatology, Rockefeller University, New York, New York, USA.
Tomalin L; Department of Population Health and Science Policy, Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, USA.
Kolbinger F; Department of Population Health and Science Policy, Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, USA.
You R; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Milutinovic M; China Novartis Institutes for BioMedical Research, Shanghai, China.

Clin Exp Dermatol ; 2023 Oct 11.

Article em En | MEDLINE | ID: mdl-37820029

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google